RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, will be presenting at the UBS Global Specialty Pharmaceuticals Conference. The Conference will take place June 2 -3, 2010 at the UBS Offices in London, United Kingdom.
